Document Detail


Rapid regression through bromocriptine therapy of a suprasellar extending prolactinoma during pregnancy.
MedLine Citation:
PMID:  2880760     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A 29-year-old woman is described who presented with amenorrhea and galactorrhea with a large prolactinoma which regressed on bromocriptine therapy. Treatment with bromocriptine was stopped when pregnancy was diagnosed but 6 weeks later the prolactinoma had regrown with suprasellar extension and lateral invasion of the cavernous sinus. When treatment with bromocriptine was reinstituted symptoms subsided within 24 h and serum prolactin concentrations fell from 54,000 mM/l to 2800 mU/l within 5 days and 500 mU/l 2 days after that. Pregnancy proceeded without complications and she entered spontaneous labor at term and delivered a healthy baby. One year after delivery, on treatment with bromocriptine, her serum prolactin concentration remains within the normal range and the CT scan shows persistence of a small prolactinoma, confined to the pituitary fossa. Bromocriptine should be the primary treatment for prolactinomas regardless of tumor size and may be safely stopped when pregnancy is desired. If pituitary tumor complications occur during pregnancy, reintroduction of treatment with bromocriptine should again be the treatment of choice.
Authors:
S L Tan; H S Jacobs
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics     Volume:  24     ISSN:  0020-7292     ISO Abbreviation:  Int J Gynaecol Obstet     Publication Date:  1986 Jun 
Date Detail:
Created Date:  1987-04-16     Completed Date:  1987-04-16     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0210174     Medline TA:  Int J Gynaecol Obstet     Country:  IRELAND    
Other Details:
Languages:  eng     Pagination:  209-15     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Bromocriptine / therapeutic use*
Female
Humans
Infant, Newborn
Pituitary Neoplasms / drug therapy,  pathology,  secretion*
Pregnancy
Pregnancy Complications, Neoplastic / drug therapy*
Prolactin / secretion*
Sella Turcica
Time Factors
Chemical
Reg. No./Substance:
25614-03-3/Bromocriptine; 9002-62-4/Prolactin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Determination of trace and bulk elements in plasma and erythrocytes of diabetic pregnant women by PI...
Next Document:  Time to conception after IUD removal: importance of duration of use, IUD type, pelvic inflammatory d...